Living-donor liver transplantation for patients with hepatocellular carcinoma in Japan: Current situations and challenge

doi:10.1016/j.hbpd.2019.11.009

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Liver transplantation has now been a standard therapy for patients with hepatocellular carcinoma (HCC) in the early stage [1] . Liver transplantation is an ideal treatment for HCC which can treat both the tumors and the underlying damaged liver and thus, has higher chance of cure than the other treatments for HCC.

Key words： Living-donor Liver transplantation Hepatocellular carcinoma

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles in this journal by
	Sugawara Y

Cite this article:

Sugawara Y. Living-donor liver transplantation for patients with hepatocellular carcinoma in Japan: Current situations and challenge. Hepatobiliary Pancreat Dis Int 2020; 19(1): 1-2. DOI:10.1016/j.hbpd.2019.11.009

URL:

http://dx.doi.org/10.1016/j.hbpd.2019.11.009 OR http://www.hbpdint.com/EN/Y2020/V19/I1/1

[1]	Qin T, Gu XQ, Jeong SS, Song YY, Liu JC, Zheng JX, Xue F, Xia Q. Impact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: A single-center experience[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(1): 3-11.